您现在位置:健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告
健康网讯:
Research Report on Chinese Thrombolytic Drug Market Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd Published: Format: Hardcopy and Adobe PDF Price: US$1,960 Contact: Mr. Bian chenghua Ms. Wu huifang Tel.: 86-10-68012929-2116/2101 Fax: 86-10-68012929-2008 E-mail: bianch@healthoo.com wuhf@healthoo.com Brief introduction: The report is targeted to present the market trend of Thrombolytic Drugs (including 9 breeds) in China。The report exposes the market scale and development trend of Thrombolytic Drugs, including sales analysis of differet breeds, market shares of different enterprises (brands), regional market analysis, basing on the statistic data from 2002 to 2005. The report contains 31 tables and figures, over 19 thousand words. The table of contents 1 Summary 2 Profile of Thrombolytic Drugs 2.1 Classification of Thrombolytic Drugs 2.2 Brief introduction of different categories 3 Sales analysis of Thrombolytic Drugs 3.1 Market scale and growth trend from 2002 to 2005 3.2 Market shares of different drugs from 2002 to 2005 3.3 Market shares of different brands (enterprises) from 2002 to 2005 4 Sales analysis of key Thrombolytic Drugs in 2005 4.1 Sales analysis of different breeds Lumbrokinase Batroxobin injection Alteplase,Rt-PA Urokinase Fibrinogenase Defibrase Streptokinase Acutobin Argatroban 4.2 suggestions for marketing
|